Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2008 Aug;18(8):831-8.
doi: 10.1089/thy.2008.0091.

Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study

James C Barton  1 , Catherine Leiendecker-Foster, David M Reboussin, Paul C Adams, Ronald T Acton, John H Eckfeldt; Hemochromatosis and Iron Overload Screening Study Research Investigators
Collaborators, Affiliations
Multicenter Study

Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study

James C Barton et al. Thyroid. 2008 Aug.

Abstract

Background: Relationships of thyroid and iron measures in large cohorts are unreported. We evaluated thyroid-stimulating hormone (TSH) and free thyroxine (T4) in white participants of the primary care-based Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Methods: We measured serum TSH and free T4 in 176 HFE C282Y homozygotes without previous hemochromatosis diagnoses and in 312 controls without HFE C282Y or H63D who had normal serum iron measures and were matched to C282Y homozygotes for Field Center, age group, and initial screening date. We defined hypothyroidism as having TSH >5.00 mIU/L and free T4 <0.70 ng/dL, and hyperthyroidism as having TSH <0.400 mIU/L and free T4 >1.85 ng/dL. Multivariate analyses were performed using age, sex, Field Center, log(10) serum ferritin (SF), HFE genotype, log(10) TSH, and log(10) free T4.

Results: Prevalences of hypothyroidism in C282Y homozygotes and controls were 1.7% and 1.3%, respectively, and of hyperthyroidism 0% and 1.0%, respectively. Corresponding prevalences did not differ significantly. Correlations of log(10) SF with log(10) free T4 were positive (p = 0.2368, C282Y homozygotes; p = 0.0492, controls). Independent predictors of log(10) free T4 were log(10) TSH (negative association) and age (positive association); positive predictors of log(10) SF were age, male sex, and C282Y homozygosity. Proportions of C282Y homozygotes and controls who took medications to supplement or suppress thyroid function did not differ significantly.

Conclusions: Prevalences of hypothyroidism and hyperthyroidism are similar in C282Y homozygotes without previous hemochromatosis diagnoses and controls. In controls, there is a significant positive association of SF with free T4. We conclude that there is no rationale for routine measurement of TSH or free T4 levels in hemochromatosis or iron overload screening programs.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Correlations of log10 serum ferritin (SF) and log10 free thyroxine (T4) in Hemochromatosis and Iron Overload Screening (HEIRS) Study participants who reported taking neither thyroid supplements nor medications to suppress thyroid function. In 160 C282Y homozygotes, the correlation was positive but not significant (p = 0.2368) (above). In 277 control subjects, the correlation was positive and significant (p = 0.0492) (below).
FIG. 1.
FIG. 1.
Correlations of log10 serum ferritin (SF) and log10 free thyroxine (T4) in Hemochromatosis and Iron Overload Screening (HEIRS) Study participants who reported taking neither thyroid supplements nor medications to suppress thyroid function. In 160 C282Y homozygotes, the correlation was positive but not significant (p = 0.2368) (above). In 277 control subjects, the correlation was positive and significant (p = 0.0492) (below).
See this image and copyright information in PMC

References

    1. Feder JN. Gnirke A. Thomas W. Tsuchihashi Z. Ruddy DA. Basava A. Dormishian F. Domingo R., Jr. Ellis MC. Fullan A. Hinton LM. Jones NL. Kimmel BE. Kronmal GS. Lauer P. Lee VK. Loeb DB. Mapa FA. McClelland E. Meyer NC. Mintier GA. Moeller N. Moore T. Morikang E. Prass CE. Quintana L. Starnes SM. Schatzman RC. Brunke KJ. Drayna DT. Risch NJ. Bacon BR. Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408. - PubMed
    1. Beutler E. Felitti V. Gelbart T. Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000;133:329–337. - PubMed
    1. Adams PC. Reboussin DM. Barton JC. McLaren CE. Eckfeldt JH. McLaren GD. Dawkins FW. Acton RT. Harris EL. Gordeuk VR. Leiendecker-Foster C. Speechley M. Snively BM. Holup JL. Thomson E. Sholinsky P. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–1778. - PubMed
    1. Barton JC. Wiener HW. Acton RT. Go RC. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Blood Cells Mol Dis. 2005;34:38–47. - PubMed
    1. Bezwoda WR. Bothwell TH. Van Der Walt LA. Kronheim S. Pimstone BL. An investigation into gonadal dysfunction in patients with idiopathic haemochromatosis. Clin Endocrinol (Oxf ) 1977;6:377–385. - PubMed

Publication types

MeSH terms